Founded in June 2023, it is an enterprise focusing on the R & D, production and sales of in vitro diagnostic reagents and related instruments and equipment. At present, a complete colloidal gold immunochro-matography platform, fluorescence immunochro-matography platform, latex microsphere immuno-chromatography platform and inspection equipment platform for supporting use of in vitro diagnostic reagents have been established. Product scope: Design, development, manufacture and distribution of in vitro diagnostic reagents and related instruments and equipment, including but not limited to drug abuse, infectious diseases, fertility testing, disease states, cardiac markers, endocrine disorders, cancer markers, immunofluorescence analyzers.